insights_auto
Why is NVZMY down 3.57%?
Dive Deeperchevron_right
NVZMY:OTCMKTS
NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
$65.02
arrow_downward
-3.57%(-2.41) 1D
Sep 25, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVZMY...
Open
$65.29
High
$65.44
Low
$64.56
Mkt. cap
175.92B
Avg. vol.
25.03K
Volume
23.42K
52-wk high
$75.26
52-wk low
$49.90
Beta
0.90
Shares outstanding
414.56M
No. of employees
11K
Open
$65.29
High
$65.44
Low
$64.56
Mkt. cap
175.92B
Avg. vol.
25.03K
Volume
23.42K
52-wk high
$75.26
52-wk low
$49.90
Beta
0.90
Shares outstanding
414.56M
No. of employees
11K
News stories
From web sources and news partners
BizTimes - Milwaukee Business News
·
2 days ago
Novonesis commits to 10 more years of West Allis investment following plant expansion completion
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About NOVONESIS NOVOZYMES B Unsponsored Denmark ADR